ECCT’s Digital Display Label (DDL) Technology is the technology being adopted by a consortium of pharmaceutical companies (see ISPE article March/April 2024 | Volume 44, Number 2).
The Digital Display Software platform DDL-Service will soon be rolled-out by one of the top 3 pharmaceutical companies, and a second top 3 pharmaceutical company will also implement ECCT’s technology on its own platform.
Later this year, clinical studies will follow, where the Digital Display Label devices will also be used.
ECCT has also started a DDL application in another pharmaceutical application, for one of the 12 pharmaceutical companies that have embraced ECCT’s technology.